Home In a twist, Teva to face generic competition
 

Keywords :   


In a twist, Teva to face generic competition

2015-04-17 00:07:31| Biotech - Topix.net

The Food and Drug Administration on Thursday approved the first generic version of Teva's top branded product, the multiple sclerosis drug Copaxone. Teva , based in Israel with its North American headquarters in North Wales, Pa., had spent several years in court battles trying to fend off competition for its MS drug.

Tags: face competition generic twist

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.11Subtropical Storm Patty Update Statement
02.11Summary for Subtropical Storm Patty (AT2/AL172024)
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
02.11Subtropical Storm Patty Graphics
02.11Subtropical Storm Patty Forecast Discussion Number 1
02.11Subtropical Storm Patty Wind Speed Probabilities Number 1
More »